+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Immunohematology Market by Product, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454916
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Immunohematology Market grew from USD 2.28 billion in 2023 to USD 2.46 billion in 2024. It is expected to continue growing at a CAGR of 7.68%, reaching USD 3.84 billion by 2030.

Immunohematology is a crucial branch of hematology concerned with the study of antigen-antibody reactions and phenomena as they relate to the pathophysiology and clinical manifestations of blood disorders. This field is vital for blood typing, cross-matching for transfusion services, and managing hemolytic disease of the newborn. The necessity of immunohematology lies in its vast applications, which include determining blood compatibility in transfusions and aiding in organ transplantation procedures. Major end-users include hospitals, blood banks, and diagnostic laboratories. The market for immunohematology has seen significant growth driven by an increased demand for blood transfusions, the prevalence of blood-related disorders, and advancements in technology. Furthermore, rising investments in healthcare infrastructure globally emphasize the importance of accurate and efficient blood screening, promoting market expansion.

Key growth influencers include a surge in healthcare expenditure, technological innovations in blood testing equipment, and the increasing prevalence of chronic diseases requiring regular blood transfusions. Opportunities surface in the advent of automated and integrated systems which offer precision and reduced human error, catering to a demand for high-throughput and cost-effective solutions. However, the market encounters challenges like stringent regulatory frameworks and the high cost of advanced immunohematology equipment. Moreover, a dearth of skilled professionals can hinder optimal adoption rates in developing regions.

To mitigate these challenges, innovation can focus on the development of point-of-care testing systems and enhancing the sensitivity and specificity of existing methodologies. Additionally, substantial research into machine learning and AI applications for predictive diagnostics and personalized medicine offers new fronts for growth. The nature of the immunohematology market is dynamic, characterized by rapidly evolving technologies and a critical need for precision, presenting both opportunities and challenges that demand continuous innovation and adaptation to ensure comprehensive healthcare solutions.

Understanding Market Dynamics in the Immunohematology Market

The Immunohematology Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing prevalence of leukemia and other hematological disorder
    • Improvements in the healthcare infrastructure and the development of blood banks and trauma centers
    • Ongoing government initiatives to increase awareness of blood donations
  • Market Restraints
    • High cost of maintenance and limited awareness
  • Market Opportunities
    • Availability of innovative transfusion systems and next-generation immunohematology devices
    • Ongoing research and development programs for the advancement of new products in immunohematology
  • Market Challenges
    • Dearth of skilled professionals and stringent regulatory policies

Exploring Porter’s Five Forces for the Immunohematology Market

Porter’s Five Forces framework further strengthens the insights of the Immunohematology Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Immunohematology Market

External macro-environmental factors deeply influence the performance of the Immunohematology Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Immunohematology Market

The Immunohematology Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Immunohematology Market

The Immunohematology Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Immunohematology Market

The Immunohematology Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunohematology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biomed Global, Cardinal Health, Inc., CSL Limited, Grifols, S.A., Immucor, Inc., Merck KGaA, Ortho-Clinical Diagnostics, Inc., Quotient Suisse S.A., Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Immunohematology Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Analyzers & Systems
    • Reagents
  • Application
    • Blood Transfusion
    • Laboratory Resolution of Percentage Problems
    • Organ Transplantation
    • Pregnancy
  • End User
    • Blood Banks
    • Diagnostic Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of leukemia and other hematological disorder
5.1.1.2. Improvements in the healthcare infrastructure and the development of blood banks and trauma centers
5.1.1.3. Ongoing government initiatives to increase awareness of blood donations
5.1.2. Restraints
5.1.2.1. High cost of maintenance and limited awareness
5.1.3. Opportunities
5.1.3.1. Availability of innovative transfusion systems and next-generation immunohematology devices
5.1.3.2. Ongoing research and development programs for the advancement of new products in immunohematology
5.1.4. Challenges
5.1.4.1. Dearth of skilled professionals and stringent regulatory policies
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Immunohematology Market, by Product
6.1. Introduction
6.2. Analyzers & Systems
6.3. Reagents
7. Immunohematology Market, by Application
7.1. Introduction
7.2. Blood Transfusion
7.3. Laboratory Resolution of Percentage Problems
7.4. Organ Transplantation
7.5. Pregnancy
8. Immunohematology Market, by End User
8.1. Introduction
8.2. Blood Banks
8.3. Diagnostic Laboratories
8.4. Hospitals
9. Americas Immunohematology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Immunohematology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Immunohematology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. IMMUNOHEMATOLOGY MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOHEMATOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. IMMUNOHEMATOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOHEMATOLOGY MARKET DYNAMICS
TABLE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY LABORATORY RESOLUTION OF PERCENTAGE PROBLEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PREGNANCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. THAILAND IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. DENMARK IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. EGYPT IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. FINLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. NORWAY IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. POLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. QATAR IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. TURKEY IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Immunohematology Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomed Global
  • Cardinal Health, Inc.
  • CSL Limited
  • Grifols, S.A.
  • Immucor, Inc.
  • Merck KGaA
  • Ortho-Clinical Diagnostics, Inc.
  • Quotient Suisse S.A.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information